Weight Watchers (WW)
By Tara ComonteFebruary 9, 2026
NewslettersExclusive: The founders of SoulCycle built a startup for relationships, then pivoted to GLP-1 support groups. Now its assets are being acquired by WeightWatchers
By Emma HinchliffeAugust 7, 2025
FinanceWeightWatchers files for bankruptcy as it struggles for a place in a weight loss world dominated by Ozempic and Wegovy
By The Associated PressMay 7, 2025
HealthHims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
By Lindsey LeakeFebruary 3, 2025
By Sasha RogelbergAugust 29, 2024
HealthExclusive: The COO of Hims & Hers was the third person to try their new weight loss drugs—and she’s ready to share her story
By Alexa MikhailAugust 14, 2024
By Emma Hinchliffe and Joey AbramsJune 11, 2024
RetailNestlé’s new foods are getting Ozempified, with slashed portions priced specifically for those on weight-loss drugs
By Sasha RogelbergMay 21, 2024
FinanceWeightWatchers, reeling from collapsing stock and Oprah’s departure in the age of Ozempic, vows to ‘prove the naysayers wrong’ and turn its fortunes around
By Amanda GerutMarch 14, 2024
LeadershipOprah to leave WeightWatchers board, donating her stake over ‘perceived conflict of interest around her taking weight loss medications’
By Amanda GerutFebruary 28, 2024
By Katrina Compoli and BloombergFebruary 1, 2024
By The Associated PressOctober 13, 2023
MagazineNovo Nordisk developed Ozempic and started a weight-loss revolution. Its next moonshot is eliminating obesity altogether
By Vivienne WaltJuly 31, 2023
Most Popular
